Nicoletta Lanese

Nicoletta Lanese is a health and medicine reporter with expertise in neuroscience and dance. She currently serves as the health channel editor at Live Science, where she covers vaccines, infections, and diseases. Her work has appeared in various publications including The Scientist, Science News, Mercury News, Mongabay and Stanford Medicine Magazine. Based in New York City, Lanese also remains active in dance and performs in local choreographers' works.

Biography:  https://www.livescience.com/author/nicoletta-lanese

78%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

92%

Examples:

  • Nicoletta Lanese reports on health and medicine with a focus on vaccines, infections, and diseases. She presents information in an accessible way for readers.
  • She has a background in neuroscience and dance which may influence her approach to reporting.

Conflicts of Interest

75%

Examples:

  • There is no direct evidence of conflicts of interest in Lanese's reporting. However, her background in dance and involvement in local choreographers' work may raise questions about potential conflicts.

Contradictions

85%

Examples:

  • In one article, Lanese reports an increase in tuberculosis cases in California but also states that the number of TB cases reported during the pandemic were higher than the reported number for last year.
  • She reports on a flu vaccine that has removed a branch of the flu family tree from its formulation, implying it's been completely eradicated while it's only gone extinct for a short period.

Deceptions

62%

Examples:

  • Lanese presents information on HIV vaccine development that could be misleading if taken out of context.
  • She implies that the Yamagata branch of the flu family tree has been completely eradicated when it's only gone extinct for a short period.

Recent Articles

Moderna's Promising Two-in-One Flu and COVID-19 Vaccine: Higher Immune Responses in Late-Stage Trials

Moderna's Promising Two-in-One Flu and COVID-19 Vaccine: Higher Immune Responses in Late-Stage Trials

Broke On: Monday, 10 June 2024 Moderna's experimental two-in-one vaccine, mRNA-1083, shows higher immune responses to both flu strains and SARS-CoV-2 in older adults compared to separate vaccines in a late-stage clinical trial. The combination shot could offer convenience and potentially hit the market as early as fall 2025.
First Human Production of Elusive HIV Antibodies in Groundbreaking Vaccine Trial

First Human Production of Elusive HIV Antibodies in Groundbreaking Vaccine Trial

Broke On: Friday, 17 May 2024 Scientists have reported success in triggering the production of rare and elusive antibodies against HIV in human patients for the first time, using a novel vaccine approach. Another innovative strategy involves selectively activating rare B cells to produce broadly neutralizing antibodies. While these advancements offer hope for an eventual HIV vaccine, researchers emphasize continued exploration and building on recent successes to develop a safe and effective solution.
Tuberculosis Cases in the US Increase by 16% in 2023, Highest Since 8,347 Reported in Previous Year

Tuberculosis Cases in the US Increase by 16% in 2023, Highest Since 8,347 Reported in Previous Year

Broke On: Sunday, 01 January 2023 The number of tuberculosis cases in the US increased by 16% from 2022 to 9,615 in 2023. This was the highest increase since before that. Most U.S TB cases are diagnosed in people born outside America.
2024-25 Flu Vaccine to Contain Trivalent Instead of Quadrivalent Formulations, Influenza B Yamagata No Longer a Public Health Threat

2024-25 Flu Vaccine to Contain Trivalent Instead of Quadrivalent Formulations, Influenza B Yamagata No Longer a Public Health Threat

Broke On: Thursday, 07 March 2024 The flu vaccine for the 2024-25 season will contain trivalent vaccines instead of quadrivalent, as recommended by a federal vaccine advisory group. This decision was made after evidence suggested that influenza B Yamagata no longer poses a public health threat.